Status:
UNKNOWN
Impact of ODYSight in the Management of patientS With imparairEd Visual acuitY
Lead Sponsor:
Tilak Healthcare
Conditions:
Impaired Visual Acuity
Eligibility:
All Genders
18+ years
Brief Summary
Previous investigations have demonstrated the agreement between OdySight® and standardised methods in the evaluation of near visual acuity. The app allows for remote monitoring of this parameter with ...
Detailed Description
Near or distance vision impairment is affecting more and more patients each year and the prevalence is about 2.2 billion people around the world. It has been estimated that in almost half of the cases...
Eligibility Criteria
Inclusion
- OdySight® user (between 07/21/2021 and 11/14/2022),
- Performed at least 3 tests on the same eye (minimum number of tests to trigger an alert).
Exclusion
- Opposition to personal data collection and processing,
- Patient's death is documented.
Key Trial Info
Start Date :
January 27 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2024
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06076785
Start Date
January 27 2023
End Date
January 31 2024
Last Update
November 7 2023
Active Locations (8)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Ophtalmologique Oculus
Chambéry, Auvergne-Rhône-Alpes, France, 73000
2
Centre Ophtalmologique Rabelais
Lyon, Auvergne-Rhône-Alpes, France, 69002
3
SELARL Dr Boulet
Évreux, Normandy, France, 27000
4
Clinique Mathilde
Rouen, Normandy, France, 76000